34 related articles for article (PubMed ID: 17197181)
1. Selective androgen receptor modulators as function promoting therapies.
Bhasin S; Jasuja R
Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):232-40. PubMed ID: 19357508
[TBL] [Abstract][Full Text] [Related]
2. Selective androgen receptor modulators in preclinical and clinical development.
Narayanan R; Mohler ML; Bohl CE; Miller DD; Dalton JT
Nucl Recept Signal; 2008; 6():e010. PubMed ID: 19079612
[TBL] [Abstract][Full Text] [Related]
3. A selective androgen receptor modulator with minimal prostate hypertrophic activity enhances lean body mass in male rats and stimulates sexual behavior in female rats.
Allan GF; Tannenbaum P; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Zhang X; Sui Z; Lundeen SG
Endocrine; 2007 Aug; 32(1):41-51. PubMed ID: 17992601
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel benzimidazolyl-substituted acrylonitriles and amidino-substituted benzimidazo[1,2-a]quinolines.
Hranjec M; Karminski-Zamola G
Molecules; 2006 Aug; 12(8):1817-28. PubMed ID: 17960071
[TBL] [Abstract][Full Text] [Related]
5. 2-(2,2,2-Trifluoroethyl)-5,6-dichlorobenzimidazole derivatives as potent androgen receptor antagonists.
Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2007 Feb; 17(4):955-8. PubMed ID: 17134895
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR of potent and selective androgen receptor antagonists: 5,6-Dichloro-benzimidazole derivatives.
Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2007 Feb; 17(3):784-8. PubMed ID: 17095226
[TBL] [Abstract][Full Text] [Related]
7. Serendipitous discovery of novel imidazolopyrazole scaffold as selective androgen receptor modulators.
Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2007 Jan; 17(2):439-43. PubMed ID: 17079140
[TBL] [Abstract][Full Text] [Related]
8. Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones.
van Oeveren A; Motamedi M; Martinborough E; Zhao S; Shen Y; West S; Chang W; Kallel A; Marschke KB; López FJ; Negro-Vilar A; Zhi L
Bioorg Med Chem Lett; 2007 Mar; 17(6):1527-31. PubMed ID: 17267219
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators.
Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
J Med Chem; 2007 Aug; 50(16):3857-69. PubMed ID: 17636947
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of potent and tissue-selective androgen receptor modulators (SARMs): 2-(2,2,2)-Trifluoroethyl-benzimidazole scaffold.
Ng RA; Lanter JC; Alford VC; Allan GF; Sbriscia T; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2007 Mar; 17(6):1784-7. PubMed ID: 17197181
[TBL] [Abstract][Full Text] [Related]
11. Selective androgen receptor modulators: in pursuit of tissue-selective androgens.
Omwancha J; Brown TR
Curr Opin Investig Drugs; 2006 Oct; 7(10):873-81. PubMed ID: 17086931
[TBL] [Abstract][Full Text] [Related]
12. [Hormone replacement Up-to-date. Selective androgen receptor modulators (SARMs). Current status and their future].
Tsukamoto T; Kato R; Kobayashi K
Clin Calcium; 2007 Sep; 17(9):1424-8. PubMed ID: 17767034
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
